About Us
Transforming Cancer Care

Gynecologic

Can the HPV Vaccine Reduce the Danger of Cervical Cancer?

Human papillomavirus (HPV) is a sexually transmitted infection that is spread through intimate, skin-to-skin contact. HPV comprises a group of more than 150 related viruses that thrive in the cells found on the skin’s surface or other moist (mucosal) surfaces.

Journal of Clinical Oncology

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

British Journal of Cancer

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10

JCO Precision Oncology

Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Investigational New Drugs

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

Gynecologic Oncology

DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma